The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family members.
D002648:Child; D002675:Child, Preschool; D003968:Diarrhea, Infantile / Q000150:complications; D004485:Eczema / Q000150:complications; D005260:Female; D006474:Hemorrhagic Disorders / Q000150:complications; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007223:Infant; D007518:Isoantibodies / Q000032:analysis; D008213:Lymphocyte Activation; D008263:Macrophage Migration-Inhibitory Factors / Q000032:analysis; D008297:Male; D009000:Monocytes / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D012882:Skin Tests; D013921:Thrombocytopenia / Q000150:complications; D014923:Wiskott-Aldrich Syndrome / Q000097:blood / Q000150:complications / Q000276:immunology*
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007518:Isoantibodies; D008263:Macrophage Migration-Inhibitory Factors